Navigation Links
VersaStep™ Plus Short Instrument with 70 mm Working Length

ProductsVersaStep™ Plus Short Instrument with 70 mm Working Length
Company Autosuture
Item VersaStep™ Plus Short Instrument with 70 mm Working Length
Features 
  • For applications in laparoscopic procedures
  • Unique endoscopic entry device that has applications in laparoscopic procedures
  • Used to establish entry into the abdominal cavity
  • 70 mm working length
  • Available in three diameters
  • 5 mm cannula and dilator with radially expandable sleeve
  • 11 mm and 12 mm cannula and dilator with or without radially expandable sleeve
  • Radially Expandable Sleeve also available separately
  • 3 units per box
  • 6 units per box (VS100700 only)
  • 12 units per box (VS070000 only)
    • Description VERSASTEP™ Plus Short Instrument for applications in laparoscopic procedures.

    The VERSASTEP™ Plus Short Instrument with 70 mm Working Length is a unique endoscopic entry device that has applications in laparoscopic procedures. It is used to establish entry into the abdominal cavity.
    Info Autosuture
    Customer Service: (800) 722-8772
    Web site: http://www.autosuture.com

    Related medicine products :

    1. VersaStep™ Plus Long Instrument with 150 mm Working Length
    2. VersaStep™ Plus Instrument
    3. VersaStep™ Reposable Powershield™ (Reusable Radiolucent Cannulae - Short Length)
    4. VersaStep™ Reposable Short Single-Use Instruments
    5. VersaStep™ SHORT Reposable (Reusable Components - Short Length)
    6. VersaStep™ Reposable (Reusable Components - Standard Length)
    7. Weiss Retinal Pick 120 Degree Short
    8. Weiss Retinal Pick 90 Degree Short
    9. Wilder Lacrimal Dilator - Short
    10. Short Handle Black
    11. Near PT Test Card/Shorthand/PH - BC2204
    Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 1DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 2DIA 8th Annual Electronic Submissions Conference Addresses Current Developments in eCTD around the World 59225 3Gene Data Tool Advances Prospects for Personalized Medicine 59221 1Gene Data Tool Advances Prospects for Personalized Medicine 59221 2Gene Data Tool Advances Prospects for Personalized Medicine 59221 3Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 1Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 2Prize4Life Marks One Year Anniversary of Avi Kremer ALS Treatment Prize 59217 3